IL44135A - Anticancer medicament containing human serum - Google Patents

Anticancer medicament containing human serum

Info

Publication number: IL44135A
Authority: IL; Israel
Prior art keywords: serum; medicament; hepatitis; blood; antigen
Prior art date: 1973-02-19

Application number

IL44135A

Other languages

English (en)

Other versions

IL44135A0 (en

Original Assignee

Soussan A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-02-19

Filing date

1974-02-04

Publication date

1976-12-31

1974-02-04 Application filed by Soussan A filed Critical Soussan A

1974-06-30 Publication of IL44135A0 publication Critical patent/IL44135A0/xx

1976-12-31 Publication of IL44135A publication Critical patent/IL44135A/en

Links

210000002966 serum Anatomy 0.000 title claims abstract 15
239000003814 drug Substances 0.000 title claims abstract 8
230000001093 anti-cancer Effects 0.000 title abstract 2
239000000427 antigen Substances 0.000 claims abstract 7
102000036639 antigens Human genes 0.000 claims abstract 7
108091007433 antigens Proteins 0.000 claims abstract 7
206010019799 Hepatitis viral Diseases 0.000 claims abstract 6
210000004369 blood Anatomy 0.000 claims abstract 6
239000008280 blood Substances 0.000 claims abstract 6
201000001862 viral hepatitis Diseases 0.000 claims abstract 6
241000700605 Viruses Species 0.000 claims abstract 5
206010028980 Neoplasm Diseases 0.000 claims abstract 4
201000011510 cancer Diseases 0.000 claims abstract 4
208000006454 hepatitis Diseases 0.000 claims abstract 4
231100000283 hepatitis Toxicity 0.000 claims abstract 4
244000052616 bacterial pathogen Species 0.000 claims abstract 3
230000001717 pathogenic effect Effects 0.000 claims abstract 3
206010023126 Jaundice Diseases 0.000 claims abstract 2
102000003929 Transaminases Human genes 0.000 claims abstract 2
108090000340 Transaminases Proteins 0.000 claims abstract 2
208000015181 infectious disease Diseases 0.000 claims abstract 2
230000002458 infectious effect Effects 0.000 claims abstract 2
230000001143 conditioned effect Effects 0.000 claims 1
238000002347 injection Methods 0.000 claims 1
239000007924 injection Substances 0.000 claims 1
241001515942 marmosets Species 0.000 claims 1
238000000034 method Methods 0.000 claims 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Cell Biology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Immunology (AREA)
Zoology (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL44135A 1973-02-19 1974-02-04 Anticancer medicament containing human serum IL44135A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR7305741A FR2218091B1 (de)	1973-02-19	1973-02-19

Publications (2)

Publication Number	Publication Date
IL44135A0 IL44135A0 (en)	1974-06-30
IL44135A true IL44135A (en)	1976-12-31

Family

ID=9115016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL44135A IL44135A (en)	1973-02-19	1974-02-04	Anticancer medicament containing human serum

Country Status (13)

Country	Link
AT (1)	AT339473B (de)
AU (1)	AU6575874A (de)
BE (1)	BE810112A (de)
DE (1)	DE2404983A1 (de)
ES (1)	ES423245A1 (de)
FR (1)	FR2218091B1 (de)
GB (1)	GB1465553A (de)
IL (1)	IL44135A (de)
LU (1)	LU69412A1 (de)
MC (1)	MC1000A1 (de)
NL (1)	NL7401983A (de)
OA (1)	OA04602A (de)
ZA (1)	ZA74655B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2685870B1 (fr) *	1992-01-03	1995-07-07	Soussan Andre	Medicament anticancereux.

1973
- 1973-02-19 FR FR7305741A patent/FR2218091B1/fr not_active Expired
1974
- 1974-01-24 BE BE140133A patent/BE810112A/xx unknown
- 1974-01-31 ZA ZA00740655A patent/ZA74655B/xx unknown
- 1974-02-01 DE DE2404983A patent/DE2404983A1/de active Pending
- 1974-02-04 IL IL44135A patent/IL44135A/en unknown
- 1974-02-08 MC MC1090A patent/MC1000A1/fr unknown
- 1974-02-13 NL NL7401983A patent/NL7401983A/xx not_active Application Discontinuation
- 1974-02-14 ES ES0423245A patent/ES423245A1/es not_active Expired
- 1974-02-18 AT AT129774A patent/AT339473B/de not_active IP Right Cessation
- 1974-02-18 LU LU69412A patent/LU69412A1/xx unknown
- 1974-02-19 GB GB748274A patent/GB1465553A/en not_active Expired
- 1974-02-19 AU AU65758/74A patent/AU6575874A/en not_active Expired
- 1974-02-19 OA OA55124A patent/OA04602A/xx unknown

Also Published As

Publication number	Publication date
ES423245A1 (es)	1976-05-01
IL44135A0 (en)	1974-06-30
ZA74655B (en)	1975-09-24
OA04602A (fr)	1980-06-30
NL7401983A (de)	1974-08-21
FR2218091B1 (de)	1976-07-02
BE810112A (fr)	1974-05-16
LU69412A1 (de)	1974-05-29
AU6575874A (en)	1975-08-21
DE2404983A1 (de)	1974-10-17
AT339473B (de)	1977-10-25
ATA129774A (de)	1977-02-15
FR2218091A1 (de)	1974-09-13
MC1000A1 (fr)	1974-10-18
GB1465553A (en)	1977-02-23

Similar Documents

Publication	Publication Date	Title
Bullock Jr et al.	1971	Studies of immune mechanisms in leprosy: III. The role of cellular and humoral factors in impairment of the in vitro immune response
Suciu-Foca et al.	1973	Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer
Ferguson et al.	1976	Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration.
AU588809B2 (en)	1989-09-28	Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions
Winston et al.	1983	Pneumococcal vaccination of recipients of bone marrow transplants
Woolf et al.	1976	Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.
Bass	1975	Behavior of eosinophil leukocytes in acute inflammation. I. Lack of dependence on adrenal function.
Cassel et al.	1977	Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses
Castaldi et al.	1963	Studies of the life span and fate of platelets
Thomas Jr et al.	1946	Demonstration of Infectious Hepatitis Virus in Presymptomatic Period after Transfer by Transfusion.∗
Francis Jr	1940	Differentiation of Influenza A and Influenza B by the Complement-Fixation Reaction.
Schrek et al.	1957	Cytotoxicity of a homologous immune serum to a transplantable rat tumor by the method of unstained cell counts
Hayes et al.	1984	Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease
Phillips et al.	1962	Passive Transfer of Immunity to Sarcoma I with Serum.
Weir et al.	1967	Intrinsic factor secretion in response to continuous histamine infusion
GB1465553A (en)	1977-02-23	Anticancer medicine
Hill et al.	1956	Sedimentation behavior of serum lactic dehydrogenase
Graw Jr et al.	1969	Priapism in a child with chronic granulocytic leukemia
Sorensen et al.	1954	Antigenic fractions specific for Histoplasma capsulatum in the complement fixation reaction
Kirk et al.	1951	Effect of oral thiamine administration on thiamine content of the stool.
Freestone et al.	1982	Transient monoclonal gammopathy in hydralazine-induced lupus erythematosus
Ireton et al.	1974	The covert liver disease of drug addicts
Kamat et al.	1977	Typhoid: Clinical picture and response to chloramphenicol: Prospective study in Bombay (1972)
Driessen et al.	1960	Haemadsorption in vaccinia-infected tube tissue cultures
Ward	1930	OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD: II. THE NEUTRALIZATION OF THE ANTI-PHAGOCYTIC ACTION OF THE SPECIFIC SOLUBLE SUBSTANCE BY ANTISERUM